Global biopharmaceutical company
Awareness of the need for access to all FDA-approved medications for treatment of substance use disorder; Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments for substance use disorder and alcohol use disorder; Initiatives to promote the use of relapse prevention post detoxification; SUPPORT Act reauthorization; Advance the use and funding of FDA-approved medicines to treat serious mental illness in criminal justice and public health settings Implementation of H.R.5376 - Inflation Reduction Act
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 1 - SENATE
SPLITOAK STRATEGIES LLC
300 New Jersey Avenue, NW, Suite 900, Washington, DC, 20001, US
SARAH KUEHL EGGE SARAH KUEHL EGGE